Vidac Pharma Holding Plc (ETR:T9G)
Germany · Delayed Price · Currency is EUR 0.4500
-0.0080 (-1.75%)
Last updated: Aug 24, 2026, 11:54 AM CET
Vidac Pharma Holding Market Cap
Vidac Pharma Holding has a market cap or net worth of €23.64 million as of August 24, 2026.
Market Cap
23.64M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.45
ChartMarket Cap Chart
Since December 15, 2025, Vidac Pharma Holding's market cap has decreased from 26.85M to 23.64M, a decrease of -11.92%. That is a compound annual growth rate of -16.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 23.64M | -14.55% |
| Dec 30, 2025 | 27.67M | 3.08% |
| Dec 15, 2025 | 26.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 225.65K |
| MagForce AG | 91.72K |